Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
3.880
+0.040 (1.04%)
Dec 8, 2025, 1:59 PM EST - Market open
Minerva Neurosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Minerva Neurosciences stock has a target of 4.00, which predicts a 3.10% increase from the current stock price of 3.88.
Price Target: $4.00 (+3.10%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Minerva Neurosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +3.10% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +28.87% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +28.87% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +28.87% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $11 → $7 | Hold | Maintains | $11 → $7 | +80.42% | May 2, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.43
from 0.19
EPS Next Year
-0.55
from -1.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.47 | -0.57 | ||||
| Avg | -1.43 | -0.55 | ||||
| Low | -1.37 | -0.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.